Page 45 - Colitis Foundation News Today

A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease (IBD), according

/PRNewswire/ -- AbbVie (NYSE: ABBV) will present further analyses on HUMIRA® (adalimumab) and the investigational uses of risankizumab (SKYRIZI®) and...

A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease (IBD), according

HUNTINGTON — To increase research on malnutrition and inflammatory bowel disease among U.S. veterans, gastroenterologist Uma Sundaram, M.D., was awarded the most prestigious grant given by the U.S. Veterans Administration

Glenn Glazer is no stranger to South Florida weather and is the newest member of the WPBF 25 First Warning Weather team. The team of six meteorologists is the most experienced, most trusted, and the only local team independently certified most accurate.

Members of the Northeast States Sign Association recently voted to fill the 14-person Board for 2022.

Bethesda, MD (Jan. 20, 2022) – The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are bringing together the

The Ontario PC party has announced its candidate in Elgin-Middlesex-London for the 2022 provincial election.

Artizan Biosciences Selects Lead Product Candidate for Inflammatory Bowel Disease Therapeutic Development Program - read this article along with other careers information, tips and advice on BioSpace

NEW HAVEN, Conn., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Artizan Biosciences, Inc. (“Artizan”), a precision medicine biotechnology company, today announced the selection of its lead product candidate, ARZC-001, for the